Market Overview:
The global circadian rhythm sleep disorder market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of circadian rhythm sleep disorders, rising awareness about the benefits of early diagnosis and treatment, and technological advancements in diagnostics and treatment options. The global circadian rhythm sleep disorder market is segmented by type into melatonin, stimulants, hypnotics, and others. The melatonin segment accounted for the largest share of the global circadian rhythm sleep disorder market in 2017 owing to its widespread use for treating delayed sleep phase syndrome (DSPS) and advanced sleep phase syndrome (ASPS). The stimulants segment is expected to grow at a highest CAGR during the forecast period due to its growing use in treating non-24-hour sleep-wake disorder (N24HSWD) and jet lag disorder.
Product Definition:
A circadian rhythm sleep disorder is a sleep disorder that is caused by a problem with the body's internal clock. These disorders can cause problems with sleeping, eating, and other daily activities. The importance of circadian rhythm sleep disorders is still being studied, but it is known that these disorders can cause health problems.
Melatonin:
Melatonin is a hormone produced by the pineal gland in response to darkness and declining light levels. It helps regulate sleep, wakefulness, and the circadian rhythm.
Stimulants:
Stimulants are drugs that mimic or increase the body's natural alertness and wakefulness hormones. They can be administered in two ways; through the mouth as a pill, liquid, or spray; and by injection. Stimulants are used to treat sleep disorders such as narcolepsy and insomnia. The most commonly used stimulant is caffeine which is found in coffee, tea, chocolate & other beverages & foods.
Application Insights:
The non-24-hour sleep-wake disorder segment dominated the global circadian rhythm sleep disorder market in 2017. Non-24 hour sleep wake rhythm is a common problem for many people around the world. According to studies, about 40% of people have a non-24 hour pattern of sleeping and waking up. The most common types of non - 24 hours patterns are advanced phase and delayed phase disorders respectively. Advanced phase delay (APhD) is more prevalent than regular or free running type of circadian rhythm Sleep Disorder (CRSD). However, research shows that CRSD affects around 25% to 30% population in developed countries like North America and Europe while 10% population suffers from APhD in comparison with other regions like Middle East & Africa where 5% population suffers from APhd respectively.
Stimulants are used as first line treatment for Delayed Sleep Phase Disorder (DSLD).
Regional Analysis:
North America dominated the market in 2017 owing to an increase in awareness about circadian rhythm disorders and a rise in healthcare expenditure. Moreover, the presence of key players such as Pfizer Inc.; Ortho-McNeil Pharmaceutical; and Allergan Plc., headquartered in this region is expected to drive the demand for global Circadian Rhythm Sleep Disorder (CRSD) market over the forecast period.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period due to increasing disposable income, growing medical tourism industry, improving healthcare infrastructure, and rising awareness among people about sleep disorder treatment options. In addition, favorable government initiatives are also expected to boost growth during this period.
Growth Factors:
- Increasing awareness about the benefits of Circadian Rhythm Sleep Disorder treatment among people.
- Rising prevalence of sleep disorders and other chronic diseases across the globe.
- Growing demand for effective and affordable therapies for Circadian Rhythm Sleep Disorder treatment.
- Technological advancements in the field of sleep disorder diagnosis and treatment options that would offer better results with fewer side effects .
Scope Of The Report
Report Attributes
Report Details
Report Title
Circadian Rhythm Sleep Disorder Market Research Report
By Type
Melatonin, Stimulants, Hypnotics
By Application
Delayed Sleep Phase, Advanced Sleep Phase Disorder, Non-24-hour Sleep-Wake Disorder, Irregular Sleep Wake Rhythm, Jet Lag Disorder, Free-Running
By Companies
Vanda Pharmaceuticals, Takeda Pharmaceutical, VU University Medical Center, The Sunbox, RaQualia Pharma, Reset Therapeutics, Servier
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Circadian Rhythm Sleep Disorder Market Report Segments:
The global Circadian Rhythm Sleep Disorder market is segmented on the basis of:
Types
Melatonin, Stimulants, Hypnotics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Delayed Sleep Phase, Advanced Sleep Phase Disorder, Non-24-hour Sleep-Wake Disorder, Irregular Sleep Wake Rhythm, Jet Lag Disorder, Free-Running
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vanda Pharmaceuticals
- Takeda Pharmaceutical
- VU University Medical Center
- The Sunbox
- RaQualia Pharma
- Reset Therapeutics
- Servier
Highlights of The Circadian Rhythm Sleep Disorder Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Melatonin
- Stimulants
- Hypnotics
- By Application:
- Delayed Sleep Phase
- Advanced Sleep Phase Disorder
- Non-24-hour Sleep-Wake Disorder
- Irregular Sleep Wake Rhythm
- Jet Lag Disorder
- Free-Running
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Circadian Rhythm Sleep Disorder Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Circadian Rhythm Sleep Disorder is a disorder that affects the body's natural sleep rhythm. People with this condition have trouble falling asleep and staying asleep, even when they are in the same bed and under the same conditions as before.
Some of the key players operating in the circadian rhythm sleep disorder market are Vanda Pharmaceuticals, Takeda Pharmaceutical, VU University Medical Center, The Sunbox, RaQualia Pharma, Reset Therapeutics, Servier.
The circadian rhythm sleep disorder market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Circadian Rhythm Sleep Disorder Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Circadian Rhythm Sleep Disorder Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Circadian Rhythm Sleep Disorder Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Circadian Rhythm Sleep Disorder Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Circadian Rhythm Sleep Disorder Market Size & Forecast, 2018-2028
4.5.1 Circadian Rhythm Sleep Disorder Market Size and Y-o-Y Growth
4.5.2 Circadian Rhythm Sleep Disorder Market Absolute $ Opportunity
Chapter 5 Global Circadian Rhythm Sleep Disorder Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Circadian Rhythm Sleep Disorder Market Size Forecast by Type
5.2.1 Melatonin
5.2.2 Stimulants
5.2.3 Hypnotics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Circadian Rhythm Sleep Disorder Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
6.2.1 Delayed Sleep Phase
6.2.2 Advanced Sleep Phase Disorder
6.2.3 Non-24-hour Sleep-Wake Disorder
6.2.4 Irregular Sleep Wake Rhythm
6.2.5 Jet Lag Disorder
6.2.6 Free-Running
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Circadian Rhythm Sleep Disorder Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Circadian Rhythm Sleep Disorder Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Circadian Rhythm Sleep Disorder Analysis and Forecast
9.1 Introduction
9.2 North America Circadian Rhythm Sleep Disorder Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Circadian Rhythm Sleep Disorder Market Size Forecast by Type
9.6.1 Melatonin
9.6.2 Stimulants
9.6.3 Hypnotics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
9.10.1 Delayed Sleep Phase
9.10.2 Advanced Sleep Phase Disorder
9.10.3 Non-24-hour Sleep-Wake Disorder
9.10.4 Irregular Sleep Wake Rhythm
9.10.5 Jet Lag Disorder
9.10.6 Free-Running
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Circadian Rhythm Sleep Disorder Analysis and Forecast
10.1 Introduction
10.2 Europe Circadian Rhythm Sleep Disorder Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Circadian Rhythm Sleep Disorder Market Size Forecast by Type
10.6.1 Melatonin
10.6.2 Stimulants
10.6.3 Hypnotics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
10.10.1 Delayed Sleep Phase
10.10.2 Advanced Sleep Phase Disorder
10.10.3 Non-24-hour Sleep-Wake Disorder
10.10.4 Irregular Sleep Wake Rhythm
10.10.5 Jet Lag Disorder
10.10.6 Free-Running
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Circadian Rhythm Sleep Disorder Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Circadian Rhythm Sleep Disorder Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Circadian Rhythm Sleep Disorder Market Size Forecast by Type
11.6.1 Melatonin
11.6.2 Stimulants
11.6.3 Hypnotics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
11.10.1 Delayed Sleep Phase
11.10.2 Advanced Sleep Phase Disorder
11.10.3 Non-24-hour Sleep-Wake Disorder
11.10.4 Irregular Sleep Wake Rhythm
11.10.5 Jet Lag Disorder
11.10.6 Free-Running
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Circadian Rhythm Sleep Disorder Analysis and Forecast
12.1 Introduction
12.2 Latin America Circadian Rhythm Sleep Disorder Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Circadian Rhythm Sleep Disorder Market Size Forecast by Type
12.6.1 Melatonin
12.6.2 Stimulants
12.6.3 Hypnotics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
12.10.1 Delayed Sleep Phase
12.10.2 Advanced Sleep Phase Disorder
12.10.3 Non-24-hour Sleep-Wake Disorder
12.10.4 Irregular Sleep Wake Rhythm
12.10.5 Jet Lag Disorder
12.10.6 Free-Running
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Circadian Rhythm Sleep Disorder Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Circadian Rhythm Sleep Disorder Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Circadian Rhythm Sleep Disorder Market Size Forecast by Type
13.6.1 Melatonin
13.6.2 Stimulants
13.6.3 Hypnotics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Circadian Rhythm Sleep Disorder Market Size Forecast by Applications
13.10.1 Delayed Sleep Phase
13.10.2 Advanced Sleep Phase Disorder
13.10.3 Non-24-hour Sleep-Wake Disorder
13.10.4 Irregular Sleep Wake Rhythm
13.10.5 Jet Lag Disorder
13.10.6 Free-Running
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Circadian Rhythm Sleep Disorder Market: Competitive Dashboard
14.2 Global Circadian Rhythm Sleep Disorder Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vanda Pharmaceuticals
14.3.2 Takeda Pharmaceutical
14.3.3 VU University Medical Center
14.3.4 The Sunbox
14.3.5 RaQualia Pharma
14.3.6 Reset Therapeutics
14.3.7 Servier
